Trump’s 200% generic tariff threat would imperil Americans: Indian pharma
The Hindu has reported a new India-focused foreign affairs development: “Trump’s 200% generic tariff threat would imperil Americans: Indian pharma.” The publisher's feed describes the story as follows: Effective August 1, 2026, all generic drugs being brought into the United States will continue to have a tariff of zero per cent for a two-year period of time, after which the tariff will be raised to 100% for a one-year period of time, and 200% thereafter, said Donald Trump Intellectual Janata
Intellectual Janata displays only original summaries of externally sourced news and links readers to the original publisher.


